BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260803
DTEND;VALUE=DATE:20261013
DTSTAMP:20260720T142608Z
CREATED:20260720T142239Z
LAST-MODIFIED:20260720T142608Z
UID:10000802-1785715200-1791849599@oncodaily.com
SUMMARY:ESMO Academy 2026
DESCRIPTION:The ESMO Academy 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place virtually from 3 August to 12 October 2026. \nThe programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty\, covering major tumour types\, clinical trial methodology\, treatment principles\, pharmacokinetics\, drug interactions\, and topics relevant to the ESMO Examination. Access is initially limited to participants registered for the ESMO Examination 2026\, while the modules will become available to all ESMO members from November 2026. Registered participants will receive access details closer to the course start date.
URL:https://oncodaily.com/event/esmo-academy-2026-546719
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_21_08-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260902T183000
DTEND;TZID=America/Halifax:20260902T183000
DTSTAMP:20260721T141827Z
CREATED:20260721T141827Z
LAST-MODIFIED:20260721T141827Z
UID:10000808-1788373800-1788373800@oncodaily.com
SUMMARY:ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place live on 2 September 2026 at 18:30 CEST. \nThe session will examine the reliability of current HRD testing\, the role of PARP inhibitors in maintenance therapy\, and the emerging potential of antibody–drug conjugates for patients with HRD-negative advanced ovarian cancer. Faculty include Isabelle L. Ray-Coquard\, Charlie Gourley\, Robert Louis Coleman\, and Kathleen Nadine Moore. Registration is available exclusively to ESMO members\, and live participants will receive a certificate of attendance and two ESMO-MORA Category 1 points. \nRegister Now.
URL:https://oncodaily.com/event/ovarian-cancer-2026-547749
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/pxbee_2026-07-21_18-11-08.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260912
DTSTAMP:20251126T131416Z
CREATED:20251126T131341Z
LAST-MODIFIED:20251126T131416Z
UID:10000410-1788998400-1789171199@oncodaily.com
SUMMARY:Molecular Analysis for Precision Oncology Congress 2026
DESCRIPTION:The Molecular Analysis for Precision Oncology (MAP) Congress 2026\, co-organized by the European Society for Medical Oncology (ESMO)\, Cancer Research UK (CRUK)\, and Unicancer\, is scheduled for 10–11 September 2026 in London\, United Kingdom. \nThis high-level\, two-day meeting will serve as a platform for experts in oncology\, molecular diagnostics\, and precision medicine to converge and exchange ideas. \nThe primary focus of the congress is to share advances in cancer research\, strengthen interdisciplinary connections\, and accelerate the translation of molecular insights – particularly concerning molecular profiling\, biomarker discovery\, and personalized treatment strategies – into routine clinical practice to improve global patient care.
URL:https://oncodaily.com/event/precision-oncology-416782
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/MAP2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260918
DTEND;VALUE=DATE:20260920
DTSTAMP:20260126T222126Z
CREATED:20260126T222113Z
LAST-MODIFIED:20260126T222126Z
UID:10000627-1789689600-1789862399@oncodaily.com
SUMMARY:ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
DESCRIPTION:The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich\, Switzerland\, from September 18–19\, 2026. \nChaired by Natalie Cook and Benedikt Westphalen\, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases\, from diagnosis to treatment\, according to current standards of care. \nThe program focuses on the reshaping of cancer care through tumour-agnostic therapies andprecision oncology\, offering participants the opportunity to learn from leaders in the field while earning 10 ESMO-MORA category 1 points. Applications for the course open with a deadline of June 3\, 2026\, and successful applicants benefit from complimentary registration and accommodation.
URL:https://oncodaily.com/event/esmo-preceptorship-447566
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260928
DTSTAMP:20260627T142318Z
CREATED:20260627T142318Z
LAST-MODIFIED:20260627T142318Z
UID:10000778-1790294400-1790553599@oncodaily.com
SUMMARY:European School of Oncology's Master in Sarcoma
DESCRIPTION:The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma\, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. \nAwarding 60 ECTS credits upon completion\, the programme combines 10 online modules\, two in-person seminars\, an internship\, and a thesis. Participants are also eligible to enrol in ESO College. \n\nApplications opened: March 2026\nApplication deadline: 1 June 2026\nProgramme start: September 2026\nSeminar 1: 25–27 September 2026 — Rome\, Italy\nSeminar 2: March 2027 — ESMO Sarcoma and Rare Cancers Congress\, Lugano\, Switzerland
URL:https://oncodaily.com/event/sarcoma-529658
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/d83fcce6fb63469c9eca24df586aa35a.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20270103
DTSTAMP:20260620T133549Z
CREATED:20260620T133549Z
LAST-MODIFIED:20260620T133549Z
UID:10000766-1790294400-1798934399@oncodaily.com
SUMMARY:European School of Oncology's Refresher Course on Sarcoma
DESCRIPTION:The European School of Oncology’s Refresher Course on Sarcoma is an advanced educational event taking place from 25 to 27 September 2026 in Rome\, Italy. \nOrganized in collaboration with the Università Campus Bio-Medico di Roma\, the program is led by Course Chair Sylvie Bonvalot (FR)\, Host Chair Bruno Vincenzi (IT)\, and College Representative Silvia Brotea-Mosoiu (RO). \nThe curriculum provides a comprehensive review of soft tissue sarcomas alongside bone\, desmoid\, pediatric\, GIST\, and uterine subtypes. It focuses directly on the WHO classification\, molecular biology\, advanced imaging\, biopsy techniques\, surgical quality standards\, and radiotherapy sequencing. Through interactive\, faculty-led clinical case discussions\, the course equips attending specialists with evidence-based strategies to optimize multidisciplinary decision-making and advance personalized patient care. \n 
URL:https://oncodaily.com/event/sarcoma-524499
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/649120323_1236242505289553_8154662109148234054_n.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261001
DTSTAMP:20260721T145557Z
CREATED:20260721T145538Z
LAST-MODIFIED:20260721T145557Z
UID:10000809-1790640000-1790812799@oncodaily.com
SUMMARY:ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
DESCRIPTION:The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29–30 September 2026 in Lugano\, Switzerland. \nThe course will focus on managing cancer-related symptoms\, cachexia\, nutritional needs\, treatment toxicities\, palliative care\, end-of-life preparation\, and communication with patients and families. Applications close on 26 July 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 11 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/cancer-patients-2026-547812
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-06_43_45-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260127T204424Z
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-448014
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR